After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
C4 Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of C4 Therapeutics Inc is $720.30M. A total of 2.19 million shares were traded on the day, compared to an average of 16.01M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CCCC has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 6 SELLs from insiders. Insiders purchased 150,199 shares during that period but sold 5,510.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CCCC has a high of $11.88 and a low of $1.06.
As of this writing, CCCC has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.55 in the last quarter, which was 16.70% higher than expectations of -$0.66.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CCCC’s latest balance sheet shows that the firm has $309.28M in Cash & Short Term Investments as of fiscal 2021. There were $42.88M in debt and $51.25M in liabilities at the time. Its Book Value Per Share was $4.07, while its Total Shareholder’s Equity was $389.61M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CCCC is Buy with a score of 4.25.
